Sort   by:  
 Page size 
UnknownPancreatic cancer and a novel MSH2 germline alteration.
Not available
S-EPMC3425611 | biostudies-literature
UnknownDNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer.
Not available
S-EPMC4844213 | biostudies-literature
UnknownStakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study.
Not available
S-EPMC8799807 | biostudies-literature
UnknownROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
Not available
S-EPMC7431863 | biostudies-literature
UnknownImproved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants.
Not available
S-EPMC6043381 | biostudies-literature
UnknownUnder-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients.
Not available
S-EPMC7921023 | biostudies-literature
UnknownMultifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutation.
Not available
S-EPMC3904950 | biostudies-literature
UnknownMutation deep within an intron of MSH2 causes Lynch syndrome.
Not available
S-EPMC4580736 | biostudies-literature
UnknownPossible genetic predisposition to lymphedema after breast cancer.
Not available
S-EPMC3311400 | biostudies-literature
UnknownPredictive functional assay-based classification of PMS2 variants in Lynch syndrome.
Not available
S-EPMC9545740 | biostudies-literature
Sort   by:  
 Page size